Objectives : Training of pharmacy technicians in non-sterile compounding unit must meet the requirements of the French good manufacturing practices. Our current training program is composed of one week companionship preceded by a theoretical course and do not allow the acquisition of all the skills and knowledge required. The formation load over the pharmacist and technician also increase due to an important turnover among the technicians.
View Article and Find Full Text PDFKey Clinical Message: Venous spasm is an important reason for complicated or failed implantations of cardiac implantable electronic devices. Prevention or risk reduction of venous spasm during cardiac implantable electronic device implantation may be achieved by ultrasound or fluoroscopic imaging prior to puncture, cephalic vein cut-down, sufficient pre- and perioperative hydration, nitroglycerin injection and effective sedation, and analgesia.
Abstract: This case report with literature review focuses on venous spasm as a potential cause for complicated implantations of cardiac implantable electronic devices.
In the context of essential drug shortages, this article reports a proof of concept for the hospital preparation of a 2% propofol injectable nanoemulsion. Two processes for propofol were assessed: mixing propofol with the commercial Intralipid 20% emulsion and a "de novo" process performed using separate raw materials (i.e.
View Article and Find Full Text PDFBackground: Given the rapidly evolving pandemic of COVID-19 in 2020, authorities focused on the repurposing of available drugs to develop timely and cost-effective therapeutic strategies. Evidence suggested the potential utility of remdesivir in the framework of an early access program. REMDECO-19 is a multicenter national cohort study assessing the ability of remdesivir to improve the outcome of patients hospitalized with COVID-19.
View Article and Find Full Text PDFUnlabelled: HIV establishes reservoirs of infected cells that persist despite effective antiretroviral therapy (ART). In most patients, the virus begins to replicate soon after treatment interruption. However, a low frequency of infected cells at the time of treatment interruption has been associated with delayed viral rebound.
View Article and Find Full Text PDF